MK-1006
- Generic Name
- MK-1006
MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Non-Insulin-Dependent
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2016-01-07
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 24
- Registration Number
- NCT00791661
A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED)
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2016-02-05
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 112
- Registration Number
- NCT00758680
A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED)
- First Posted Date
- 2008-09-23
- Last Posted Date
- 2016-02-05
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 25
- Registration Number
- NCT00757601
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath